NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025
Timothy D. Gilligan, Daniel W. Lin, Nabil Adra, Aditya Bagrodia, Darren R. Feldman, Kosj Yamoah, Rahul Aggarwal, Thenappan Chandrasekar, Daniel N. Costa, Alexandra Drakaki, Scott E. Eggener, Hamid Emamekhoo, Daniel M. Geynisman, Laura Graham, Peter A. Humphrey, Harshraj Leuva, Ellis G. Levine, Amy N. Luckenbaugh, Benjamin L. Maughan, Bradley A. McGregor, Paul Monk, Joel Picus, Phillip M. Pierorazio, Soroush Rais‐Bahrami, Zachery R. Reichert, Jean‐Claude M. Rwigema, Philip J. Saylor, Ankeet Shah, Sumit Shah, Nirmish Singla, Kanishka Sircar, David James VanderWeele, Ali Zhumkhawala, Sarah Montgomery, Bailee Sliker
Abstract
The NCCN Guidelines for Testicular Cancer provide recommendations for the multidisciplinary approach to the diagnostic workup, treatment, and follow-up for testicular germ cell tumors, including both seminoma and nonseminoma. These NCCN Guidelines Insights discuss the current treatment recommendations and supporting clinical data for seminomas as presented in Version 2.2025 of the NCCN Guidelines for Testicular Cancer.